# Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

> **NCT05776953** · PHASE4 · RECRUITING · sponsor: **Hackensack Meridian Health** · enrollment: 86 (estimated)

## Conditions studied

- Renal Colic
- Flank Pain
- Emergencies
- Analgesia

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT05776953
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-21
- **Primary completion:** 2026-03-28
- **Final completion:** 2026-03-28
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05776953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05776953, "Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05776953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*